{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 2.0826454, "regularMarketPrice": 0.3088, "exchange": "ASE", "shortName": "Cybin Inc.", "longName": "Cybin Inc.", "messageBoardId": "finmb_666815486", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1568381400000, "priceHint": 4, "earningsTimestampEnd": 1644526800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.21, "epsForward": -0.2, "epsCurrentYear": -0.22, "priceEpsCurrentYear": -1.4036365, "sharesOutstanding": 189220000, "bookValue": 0.295, "fiftyDayAverage": 0.36852, "fiftyDayAverageChange": -0.05971998, "fiftyDayAverageChangePercent": -0.16205357, "twoHundredDayAverage": 0.494305, "twoHundredDayAverageChange": -0.185505, "twoHundredDayAverageChangePercent": -0.3752845, "marketCap": 60881156, "forwardPE": -1.544, "priceToBook": 1.0467798, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Cybin, Inc.", "nameChangeDate": "2023-05-15", "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.0063000023, "regularMarketTime": 1684180800, "regularMarketDayHigh": 0.311, "regularMarketDayRange": "0.285 - 0.311", "regularMarketDayLow": 0.285, "regularMarketVolume": 776472, "regularMarketPreviousClose": 0.3025, "bid": 0.0, "ask": 0.311, "bidSize": 8, "askSize": 18, "fullExchangeName": "NYSE American", "financialCurrency": "CAD", "regularMarketOpen": 0.3039, "averageDailyVolume3Month": 1218256, "averageDailyVolume10Day": 963490, "fiftyTwoWeekLowChange": 0.043800026, "fiftyTwoWeekLowChangePercent": 0.16528313, "fiftyTwoWeekRange": "0.265 - 1.14", "fiftyTwoWeekHighChange": -0.8312, "fiftyTwoWeekHighChangePercent": -0.7291228, "fiftyTwoWeekLow": 0.265, "fiftyTwoWeekHigh": 1.14, "earningsTimestamp": 1644526800, "earningsTimestampStart": 1644526800, "displayName": "Cybin", "symbol": "CYBN"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "100 King Street West", "address2": "Suite 5600", "city": "Toronto", "state": "ON", "zip": "M5X 1C9", "country": "Canada", "website": "https://www.cybin.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.", "fullTimeEmployees": 50, "companyOfficers": [{"maxAge": 1, "name": "Mr. Eric  So L.L.B., LLB", "age": 46, "title": "Co-Founder, Pres & Exec. Chairman", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 461166, "fmt": "461.17k", "longFmt": "461,166"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Douglas L. Drysdale", "age": 52, "title": "Chief Exec. Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 511909, "fmt": "511.91k", "longFmt": "511,909"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul  Glavine", "age": 33, "title": "Co-Founder, Chief Growth Officer & Director", "yearBorn": 1989, "fiscalYear": 2022, "totalPay": {"raw": 461166, "fmt": "461.17k", "longFmt": "461,166"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Kanakis", "age": 42, "title": "Co-Founder", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": {"raw": 700798, "fmt": "700.8k", "longFmt": "700,798"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Greg  Cavers", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 195117, "fmt": "195.12k", "longFmt": "195,117"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aaron  Bartlone", "title": "Chief Operating Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Alex L. Nivorozhkin Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Leah  Gibson", "title": "VP of Investor Relations & Strategic Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lori  Challenger", "title": "Chief Compliance, Ethics & Admin. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gabriel  Fahel", "age": 46, "title": "Chief Legal Officer & Corp. Sec.", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}